We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations


Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

UK’s Minister for Life Sciences celebrates the success of GM AHSN’s Innovation Nexus

Speaking at the Health & Social Care Expo in Manchester last week, Minster George Freeman spoke of the current opportunities and challenges facing the NHS.

In the speech, which closed the event at Manchester Central Convention Complex, Mr Freeman set out plans for delivering the necessary improvements, focusing on NHS England’s Five Year Forward View.

Commenting on the need for  “a culture across the health and care service that values and promotes innovation”, the Minister highlighted GM AHSN’s Innovation Nexus as a prime example, noting its success in securing additional funding and supporting 60 companies in its first six months.

In addition, Mr Freeman mentioned the importance of data and digital healthcare, stressing the importance of integrated health and care records for reducing hospital admissions, supporting those with chronic conditions and decreasing the onset of preventable diseases.

Concluding, he stated: “Working with new transformative technologies towards a more innovative NHS that delivers better value. That’s what we should all be working for.”